The demand for bioresorbable-based medical implants and wound dressing covers is increasing due to their self-dissolving properties in the human body. Bioresorbable polymers such as polylactic acid, polycaprolactone, and polydioxanone are widely used to manufacture screws, pins, rods, plates scaffolds, sutures, stents, and other medical implant devices. Furthermore, these polymers are also used as controlled drug release implants inside the human body. Once the recovery of the patients’ organs begins, these implants gradually start dissolving and are entirely absorbed in the body after the fulfillment of their function. As the body itself absorbs these bioresorbable implants, patients do not require a second surgical intervention to remove them. Thus, improved clinical outcomes and cost-effectiveness associated with these implants are supporting the market growth. Further, bioresorbable polymers are witnessing a surge in their demand due to their increased applications for wound management. Bioresorbable-based synthetic polymer wraps are widely used for wound dressing and covering since they provide a barrier against bacterial penetration as well as oxygen permeability to the wound. The polymer is also used to manufacture bioresorbable wraps and sheets that are extremely thin and transparent foils capable of holding tissue masses in place and facilitating post-surgery healing. In addition, bioresorbable polymer powders are used for dermal filler applications. Dermal fillers, also known as soft tissue fillers, are injected into the skin using a minor surgical procedure to plump thin lips, enhance shallow contours, soften facial creases, remove wrinkles, and improve the appearance of scars.
The US reported the highest number of COVID-19 cases among all key countries in North America, which obstructed manufacturing processes, research, and development activities in the region. The shutdown of manufacturing other operational units hampered the bioresorbable polymer market. The halt in the production of medical devices and delays in non-essential surgeries during the pandemic also hampered the market growth in 2020. A study on orthopedic surgery volumes by the Journal of Bone and Joint Surgery, in May 2020, stated that the US is expected to face a cumulative backlog of more than a million total joint and spine surgery cases by mid-2022, which will limit the demand of medical implants. However, the reopening of manufacturing facilities after the relaxation on lockdown is aiding the resurgence of the bioresorbable polymer market activities.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America bioresorbable polymers market at a good CAGR during the forecast period.
North America Bioresorbable Polymers Market Segmentation
Strategic insights for the North America Bioresorbable Polymers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,189.92 Million |
Market Size by 2028 | US$ 2,499.56 Million |
Global CAGR (2021 - 2028) | 11.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Bioresorbable Polymers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America Bioresorbable Polymers Market is valued at US$ 1,189.92 Million in 2021, it is projected to reach US$ 2,499.56 Million by 2028.
As per our report North America Bioresorbable Polymers Market, the market size is valued at US$ 1,189.92 Million in 2021, projecting it to reach US$ 2,499.56 Million by 2028. This translates to a CAGR of approximately 11.2% during the forecast period.
The North America Bioresorbable Polymers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Bioresorbable Polymers Market report:
The North America Bioresorbable Polymers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Bioresorbable Polymers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Bioresorbable Polymers Market value chain can benefit from the information contained in a comprehensive market report.